INFECTIVE DOSE OF FOODBORNE PATHOGENS IN VOLUNTEERS: A REVIEW

Journal of Food Safety - Tập 21 Số 1 - Trang 49-68 - 2001
Mahendra H. Kothary1, Uma S. Babu1
1U.S. Food and Drug Administration Division of Virulence Assessment 200 C Street, S.W. Washington, DC 20204

Tóm tắt

ABSTRACT Risk assessment and impact of foodborne pathogens on the health of different populations was one of the goals identified in the Presidential Food Safety Initiative three‐year plan. This entailed estimation of dose‐response relationship for foodborne pathogens to humans, either by feeding studies or from outbreaks. For certain pathogens, such as Listeria monocytogenes and Escherichia coli O157:H7, there are no feeding studies due to ethical reasons, and the results from outbreaks are normally used to estimate the infectious dose. The focus of this review is to compile dose‐response information in volunteers for several foodborne pathogens including Salmonella, Shigella spp., Campylobacter jejuni, Vibrio spp., Escherichia coli, Cryptosporidium parvum and Entamoeba coli. The infectious dose for different serovars of Salmonella and strains of E. coli was quite large (> 105 organisms), while the infectious dose for some Shigella spp. seemed to be as low as less than 10 organisms. Toxigenic V. cholerae (O1 and O139 serotypes) were infective at a dose of 104 organisms; a non‐O1 strain was infective at a much higher dose (106 organisms). C. jejuni, C. parvum and Entamoeba coli appeared to have infectious doses as low as 500 organisms, 10 oocysts, and 1 cyst, respectively. The infectious dose and the dose response are dependent upon the strains used, and the age and physical condition of the individuals, and can therefore show wide variations. In addition, since many of the volunteer studies are carried out by feeding the organisms in a nonfood matrix after neutralizing the stomach acidity, results obtained may not reflect the true dose response.

Từ khóa


Tài liệu tham khảo

Aiso K.andFujiwara K.1963.Feeding tests of “pathogenic halophilic bacteria”. Annual Report of the Institute of Food Microbiology Chiba University 15 34–38.

Besser‐Wiek J.W., 1995, Foodborne outbreak of diarrheal illness associated with Cryptosporidium parvum‐Minnesota, 1995, MMWR, 45, 783

10.1093/infdis/157.3.472

10.1093/infdis/155.6.1260

10.1128/IAI.55.5.1116-1120.1987

10.1093/clinids/4.6.1096

10.1093/infdis/129.1.45

10.1093/infdis/173.1.232

10.4269/ajtmh.1999.60.157

Cohen M.B., 1999, Validation and characterization of a human volunteer challenge model for cholera by using frozen bacteria of the new Vibrio cholerae epidemic serotype, O139, Infect. Immun., 67, 6346, 10.1128/IAI.67.12.6346-6349.1999

10.1128/IAI.67.7.3437-3443.1999

10.1093/oxfordjournals.aje.a114151

10.1016/S0315-5463(75)73804-X

10.1172/JCI116717

Donnenberg M.S., 1998, Effect of prior experimental human enteropathogenic Escherichia coli infection on illness following homologous and heterologous rechallenge, Infect. Immun., 66, 52, 10.1128/IAI.66.1.52-58.1998

10.1056/NEJM199503303321304

10.1056/NEJM197107012850101

10.1093/infdis/119.3.296

10.1093/infdis/125.1.12

10.1093/infdis/159.6.1126

10.1111/j.1574-6968.1988.tb02363.x

10.1111/j.1574-6968.1988.tb02485.x

10.1016/0016-5085(84)90091-X

Fergusan W.W., 1952, Experiments on feeding adult volunteers with Escherichia coli 111, B4, a coliform organism associated with infant diarrhea, Am. J. Hyg., 55, 155

10.1093/oxfordjournals.aje.a112892

10.1086/514227

10.1136/bmj.286.6375.1394

June R.C., 1953, Experiments in feeding adult volunteers with Escherichia coli 55, B5, a coliform organism associated with infant diarrhea, Am. J. Hyg., 57, 222

Kasai G.J., 1971, Studies on the pathogenicity of Vibrio parahaemolyticus., Southeast Asian J. Trop. Med. Pub. Hlth., 2, 169

10.1093/infdis/172.4.1126

10.1016/0264-410X(94)00011-B

10.1016/0264-410X(95)00102-7

Levine M.M., 1978, Escherichia coli strains that cause diarrhea but do not produce heat labile or heat‐stable enterotoxins and are non‐invasive, Lancet, 1, 1119, 10.1016/S0140-6736(78)90299-4

Levine M.M., 1982, Reactogenicity, immunogenicity and efficacy studies of Escherichia coli Type I somatic pili parenteral vaccine in man, Scand. J. Infect. Dis. Suppl., 33, 83

Levine M.M., 1981, Acute Infections in Children. New Prospects for Treatment and Prevention, 443

Levine M.M., 1977, Diarrhea caused by Escherichia coli that produce only heat‐stable enterotoxin, Infect. Immun., 17, 78, 10.1128/iai.17.1.78-82.1977

10.1093/infdis/127.3.261

10.1128/IAI.56.1.161-167.1988

10.1093/infdis/152.3.550

10.1093/infdis/136.4.577

10.1093/infdis/166.5.1181

10.1093/infdis/154.3.524

Mccullough N.B., 1951, Experimental Human Salmonellosis; II. Immunity studies following experimenatal illness with Salmonella meleagridis & Salmonella anatum, J. Immunol., 66, 595

10.1093/infdis/88.3.278

10.1093/infdis/89.3.209

10.1093/infdis/89.3.259

10.1016/0168-1605(96)00994-4

Millard P.S., 1994, An outbreak of Cryptosporidiosis from fresh pressed apple cider, JAMA, 272, 1592, 10.1001/jama.1994.03520200048034

10.1093/infdis/171.4.903

10.1172/JCI114494

Munoz C., 1995, Characteristics of Shigella sonnei infection of volunteers: signs, symptoms, immune responses, changes in selected cytokines and acutephase substances, Am. J. Trop. Med. Hyg., 53, 47, 10.4269/ajtmh.1995.53.47

10.1093/infdis/171.2.465

10.1086/315033

10.1086/516374

Rendtorff R.C., 1954, The experimental transmission of human intestinal protozoan parasites. I. Endamoeba coli cysts given in capsules, Am. J. Hyg., 59, 196

10.1136/bmj.282.6276.1584

10.1128/IAI.66.5.1968-1972.1998

10.7883/yoken1952.21.325

Sanyal S.C., 1974, International Symposium on Vibrio parahaemolyticus, 227

10.1007/BF01645294

Jacket C.O., 1992, Efficacy of bovine milk immunoglobulin concentrate in preventing illness after Shigella flexneri challenge, Am. J. Trop. Med. Hyg., 47, 276, 10.4269/ajtmh.1992.47.276

Tacket C.O., 1999, Randomized, double‐blind, placebo‐controlled, multicentered trial of the efficacy of a single dose of live oral cholera vaccine CVD 103–HgR in preventing choleea following challenge with Vibrio cholerae O1 E1 Tor Inaba three months after vaccination, Infect. Immun., 67, 6341, 10.1128/IAI.67.12.6341-6345.1999

Tacket C.O., 1997, Volunteer studies investigating the safety and efficacy of live oral E1 Tor Vibrio cholerae O1 vaccine strain CVD 111, Am. J. Trop. Med. Hyg., 56, 533, 10.4269/ajtmh.1997.56.533

10.1086/315157

10.1093/infdis/172.3.883

10.1093/infdis/166.4.837

10.1093/infdis/162.2.550

Takikawa I., 1958, Studies on pathogenic halophilic Vibrio bacteria, Yokohama Med. Bull., 9, 313

Taylor D.N., 1984, An outbreak of salmonellosis associated with a fatality in a healthy child: a large dose & severe illness, Am. J. Epidemiol., 119, 907, 10.1093/oxfordjournals.aje.a113813

10.1093/infdis/170.6.1518

10.3181/00379727-91-22338